key: cord-1013474-z66jmz0g authors: Lysaght, Tamra; Ballantyne, Angela; Toh, Hui Jin; Lau, Andrew; Ong, Serene; Schaefer, Owen; Shiraishi, Makoto; van den Boom, Willem; Xafis, Vicki; Tai, E Shyong title: Trust and Trade-Offs in Sharing Data for Precision Medicine: A National Survey of Singapore date: 2021-09-16 journal: J Pers Med DOI: 10.3390/jpm11090921 sha: d07779834fa6ddd510b894853b6d4c35d9ba3938 doc_id: 1013474 cord_uid: z66jmz0g Background: Precision medicine (PM) programs typically use broad consent. This approach requires maintenance of the social license and public trust. The ultimate success of PM programs will thus likely be contingent upon understanding public expectations about data sharing and establishing appropriate governance structures. There is a lack of data on public attitudes towards PM in Asia. Methods: The aim of the research was to measure the priorities and preferences of Singaporeans for sharing health-related data for PM. We used adaptive choice-based conjoint analysis (ACBC) with four attributes: uses, users, data sensitivity and consent. We recruited a representative sample of n = 1000 respondents for an in-person household survey. Results: Of the 1000 respondents, 52% were female and majority were in the age range of 40–59 years (40%), followed by 21–39 years (33%) and 60 years and above (27%). A total of 64% were generally willing to share de-identified health data for IRB-approved research without re-consent for each study. Government agencies and public institutions were the most trusted users of data. The importance of the four attributes on respondents’ willingness to share data were: users (39.5%), uses (28.5%), data sensitivity (19.5%), consent (12.6%). Most respondents found it acceptable for government agencies and hospitals to use de-identified data for health research with broad consent. Our sample was consistent with official government data on the target population with 52% being female and majority in the age range of 40–59 years (40%), followed by 21–39 years (33%) and 60 years and above (27%). Conclusions: While a significant body of prior research focuses on preferences for consent, our conjoint analysis found consent was the least important attribute for sharing data. Our findings suggest the social license for PM data sharing in Singapore currently supports linking health and genomic data, sharing with public institutions for health research and quality improvement; but does not support sharing with private health insurers or for private commercial use. Precision medicine (PM) broadly aims to provide more tailored care to patients based on genomic data analytics combined with other clinical, environmental and behavioral information [1, 2] . The United States [3] , United Kingdom [4] , China [5] and several other countries are investing in PM programs with the goal to improve population health outcomes. PM programs typically seek broad consent from participants to store and share data with healthcare professionals and researchers at publicly funded institutions, as well as potentially with private enterprise and commercial partners. This model removes the need to obtain informed consent from participants each time the data are accessed for a specific purpose. However, it also relies on maintaining a social license for the program to operate without specific consent and with an implicit assumption that use of the data meets community expectations [6] . The ultimate success of PM programs will thus likely be contingent upon identifying public expectations about data sharing and management and establishing appropriate governance structures. International literature on public preferences and attitudes towards health data sharing identifies numerous issues influencing the willingness of people to participate in PM, in particular privacy, risk minimization, data security, control, transparency, accountability, trust and the social value of the research [7] . The prior research suggests that, when given the option, people would prefer to have greater control over their health data [8] [9] [10] [11] [12] [13] [14] . However, other studies indicate that people may be willing to accept less control over their health data in exchange for public benefits [15] . In real life, decision-making requires trade-offs between competing values, and decision-based experiments have shown that respondents give greater weight to the potential benefits of health data sharing than the possible risk of privacy-related harms [16] [17] [18] . While in other research that considered tradeoffs, participants gave priority to non-consensual uses of data provided that adequate privacy protections were in place and public benefits arising from the research were evident [19] . The existing empirical literature on public attitudes to genomics has been conducted primarily in Europe, North America and Australia, with a few studies done in Asia. The under-representation of Asian perspectives is problematic because it cannot be assumed that people everywhere perceive the issues and prioritize values in the same way. Some studies suggest that low participation rates of Asian minority populations in biobanks are due to cultural views about the sacredness of blood [20] and fear of discrimination [21] . As the parameters of any social license are likely to be culturally sensitive and context-specific, it is important to ensure diverse perspectives are included in the attitudinal research around genomics [22] . We report results of a nationally representative survey using adaptive choice-based conjoint analysis to measure the priorities and preferences that Singaporeans hold in relation to sharing health-related data for PM. Singapore is an ethnically diverse, city-island state in Southeast Asia with a high-income economy, robust health system, and national IT infrastructure for data storage and sharing [23, 24] . In 2020, the Singapore government launched its ten-year National Precision Medicine (NPM) program [25] . Prior empirical studies have indicated that Singaporeans may be willing to participate in PM without the need for specific consent conditional upon robust data security systems, trustworthy governance, and public benefits [26, 27] . However, it is unclear which attributes of data sharing are most important to Singaporeans. Understanding the relative importance of different data sharing arrangements will be crucial in establishing governance structures that reflect local priorities and values. Thus, our specific aims were to measure the relative value Singaporeans attribute to key data sharing arrangements, their willingness to share de-identified health data with broad consent, and their trust in various institutions using the data. We also aimed to determine what, if any, demographic features may influence these attitudes. We recruited a stratified random sample of n = 1000 respondents of Singapore citizens and permanent residents for an in-person household survey. The data collection was outsourced to professional surveyors with knowledge and experience in conducting inperson household surveys in the multi-lingual and multi-ethnic context of Singapore (Projective Insights Consultants Pty Ltd, Singapore). The research team supervised the senior surveyor who conducted regular audits for data quality assurance. Households were identified from the Department of Statistics (DOS), Singapore Sampling Frame for 2019 [28] and randomly selected with stratified and quota sampling to ensure demographic representation. Singapore's resident population is majority Chinese with minority Malay and Indian ethnic groups. To ensure adequate representation of the minority groups, Malay and Indian households were over-sampled by 3.0 and 7.5 percentage points, respectively, based on the DOS Sampling Frame (Supplementary Table S1 ). One respondent was chosen from the selected household and screened according to the eligibility criteria (i.e., population quota breakdown by age, sex and race) with household members deciding who would respond to the survey if more than one was eligible. Anyone from market research, public relations, the media, and pharmaceutical, medical or healthcare industry was also excluded to reduce bias. In the event that no household members were eligible or consented to the survey, or no one answered the door after three attempts, a replacement housing unit was sought to the right of the selected household (see Supplementary Materials for further details). The survey was developed based on findings from focus groups conducted as part of our mixed methods study [27, 29] and an instrument designed for a conjoint analysis of public preferences for health data sharing arrangements in the United States [17] . Conjoint analysis estimates how people make complex decisions by balancing or making a trade-off between competing factors [30] and can be used to quantify numerous metrics simultaneously by presenting a series of side-by-side comparisons of scenarios with different attributes or features that respondents can choose from [31] . Different types of conjoint analyses are available, but we selected an adaptive choice-based conjoint (ACBC) analysis because it adapts and modifies the scenarios and options in response to input from the survey respondent. This approach has greater accuracy as it removes redundant options that the respondent will not select or does not choose as essential features of the preferred data sharing arrangement, and it more closely resembles the way choices are made in real-life than static survey questions. The survey instrument was designed and administered using Lighthouse Studio from Sawtooth Pty Ltd, Utah, USA. [32] , which specializes in software for ACBC analysis. The survey was divided into four sections: willingness to share data, trust in institutions, trade-offs in data sharing arrangements, and demographics. Willingness to share data: This section comprised nominal scale questions asking about respondents' willingness to share de-identified data under a model of broad consent and their reasons. Trust in institutions: This section comprised 6-point Likert-scale questions (6-'totally trust' to 1-'totally distrust') asking respondents to rate how much they would trust a list of thirteen institutions/organizations to use their data. Two organizations (Ministry of Health and Facebook) were named specifically because these they have a high public profile and we were interested in the public response to a recognized organization. Trade-offs in data sharing arrangements: This section comprised: (i) preliminary questions to adapt scenarios presented to each respondent, and then (ii) three different scenarios (each with four attributes) were presented side-by-side repeatedly for the ACBC analysis. We used the four attributes uses, users, data sensitivity and consent with the following options: • Uses-the purposes respondents are willing to share data for. i. Health research; ii. Quality improvement; iii. Commercial uses. Users-with whom respondents are willing to share data. i. Government agencies; ii. Private insurers; iii. Pharmaceutical/biotech companies; iv. Universities/research institutes; v. Hospitals. • Data sensitivity-the types of data respondents would be sharing. i. Identifiable genetic data and your medical history; ii. Identifiable genetic data without your medical history; iii. De-identified genetic data and your de-identified medical history; iv. De-identified genetic data without your medical history. Consent-the degree of control over the data. i. Consent for every study; ii. One time consent only for all studies; iii. Consent for some specific studies. Demographics: This section asked for standard demographic information to evaluate the representativeness of the sample in terms of age, gender and ethnicity, to test for relationships between these characteristics and survey responses, as well as level of education, household type and income, religious identity, and respondents self-assessed health status. The instrument was pilot tested with 20 respondents before being launched and refined to minimize the duration and respondent fatigue. Prior to starting the survey, the interviewers showed respondents a short 2-3 min video demonstrating the concept of PM [33] and flash cards with definitions of key terms (see Supplementary Materials). For ethnic Chinese and Malay households, the survey and supporting information was translated into Mandarin and Malay for respondents who preferred to respond in their mother tongue. Interviews took an average of seven minutes and respondents were given a SGD 10 (~USD 7.50) shopping voucher as a token of appreciation for completing the survey. The research team supervised the lead survey administrator who conducted regular audits to verify data quality. Confidence intervals for the institutional trust scores were computed based on t statistics. Additionally, we considered Spearman's rank correlation coefficients between scores of any pair of institutions. The ACBC responses were analyzed in Lighthouse Studio [32] using hierarchical Bayes with weighting of respondents to account for the over-sampling of Malay and Indian households according to the Singapore government demographic statistics (i.e., 76.0% Chinese, 15.0% Indian, 7.5% Malay and 1.5% Others) [34] . Conjoint analysis estimates a numerical score, called utility, for each scenario. A scenario with a higher utility is more likely to be preferred over one with a lower utility. Additionally, ACBC estimates a utility threshold above which most respondents are willing to share their data. Specifically, the analysis estimates part-worth utilities for each level of each attribute. The total utility of a scenario then derives from these part-worth utilities. Importance, which is a score of how influential an attribute is for the respondents' choices, is derived from the part-worth utilities. In addition to performing ACBC analysis on all responses, we ran separate analyses on various demographic subgroups. Below, we discuss choice simulations that use the method "randomized first choice" and were based on the ACBC results. The National University of Singapore Institutional Review Board granted an exemption from ethical review (S-20-145E). All participants gave their verbal consent and received an information sheet explaining the aims, benefits and risks of the study. Twenty-one interviewers surveyed the final sample size of n = 1000 once they had disbursed all the shopping vouchers. Fifty-five (55) surveys were partially completed and excluded from the analysis. The number of completed surveys over the number of those started (1055) resulted in a high compliance rate of 95%, which was likely bolstered by the relatively short duration of the survey (average 7 min), the reputation of the authorization institution, and the shopping voucher. Interviewers did not systematically record the number of households approached from the sampling frame and the number that had an ineligible household member to complete the survey. Based on estimates for these numbers, the response rate was between 32% and 43% (Supplementary Table S2 ). Table 1 summarizes demographic and socio-economic characteristics, and Figure 1 summarizes the reasons on willingness to share data. The demographics and socioeconomic variables generally reflect the characteristics of the resident population of Singapore (i.e., citizens and permanent residents) between the ages 21 years and 85 notwithstanding the over-sampling of Malays and Indians. Per Figure 1 , slightly less than two-thirds (64%) were willing to share de-identified health data with institutions for IRB-approved research without consent for each study. Among those, 67% selected the option 'potential benefits of health research are greater than the potential risks', and 19% chose 'it would be too troublesome to consent to every study' as one of their reasons. Of the 36% who were unwilling to share data without giving consent for each study, 60% chose the option 'to have control at all times', and 35% opted for 'don't trust the research processes and protections'. In Figure 2 , respondents indicated higher levels of trust in public institutions, especially in the Singapore government, than the private sector. Supplementary Table S3 contains Spearman's correlation coefficients between trust scores. Scores among public institutions were either moderately or strongly correlated (correlation ranging from 0.44 to 0.93). Conversely, correlations between public and private institutions were weaker, ranging from 0.11 to 0.47, except for a correlation of 0.53 between pharmacies and pharmaceutical companies. Overseas universities had weak to moderate correlation with public institutions, but a higher correlation with private entities such as Facebook (R = 0.50), private insurers (R = 0.77), pharmaceutical companies (R = 0.77), and private genetic testing companies (R = 0.79). Mean trust scores for institutions using de-identified health data for Institutional Review Board approved research. A score of 6 represents "trust totally" and 1 represents "distrust totally". The whiskers indicate 95% confidence intervals. As per ACBC results shown in Figure 3 , the users attribute was the most influential deciding factor in their choice to share data. The uses attribute was the second most influential, while data sensitivity, and then consent were the least influential. The partworth utilities for the users reflect their trust scores, with the highest utility for government agencies. Relatedly for the attribute uses of the data, respondents were least willing to share data for commercial purposes. Respondents were more willing to share data in scenarios which included medical history in "data sensitivity" than those that did not. The Part-worth utilities of the attribute levels and their importance from the ACBC analysis. A higher utility corresponds with increased willingness to share data. The width of the boxes corresponds with 95% confidence intervals. The part-worth utilities and the acceptance threshold derived from ACBC can be summarized via simulation of what proportion of respondents would deem a specific scenario acceptable. Supplementary Table S4 contains simulation results with 95% confidence intervals indicating statistical significance. They reveal that most respondents found it acceptable to share de-identified data for government agencies and hospitals for the purpose of health research irrespective of the consent model (ranging between 76 and 88% for government and 71 and 85% for hospitals depending on consent type and data sensitivity). This level of acceptance was significantly greater than universities/research institutes (48-66%), pharma/biotech companies (31-49%) and insurers (14-27%). Acceptability for all users was also significantly less when sharing data for quality improvement than health research (62-76% for government; 52-74% for hospitals; 33-51% for universities/research institutes; 20-35% for pharma/biotech; and 9-18% for insurers). Commercial/private uses were widely held as unacceptable for all users with responses ranging from 62% for government to 98% for insurers. Respondents did not distinguish greatly between consent for every study versus some studies, but one-time consent was significantly less acceptable across all scenarios. Finally, we conducted subgroup analyses. Supplementary Figures S1-S8 suggest that certain demographic variables may be associated with preferences for certain levels of attributes over others. However, when we analyzed the choice-based simulations for these subgroups with 95% confidence intervals, many of the apparent differences were statistically insignificant. As shown in Supplementary Table S5, we found statistically significant differences between 21 and 39 years and 60 and above year age groups with younger respondents being more likely to share de-identified data for the purpose of health research when the users were universities, pharma/biotech companies and private insurers. Higher income earners (>SGD 10 k/month) were statistically more likely to share de-identified data for health research with universities/research institutes and pharma/biotech companies than the lowest income bracket (